Reference
Serrano L, et al. Vitiligo associated with mogamulizumab. Journal of the American Academy of Dermatology 87 (Suppl.): AB219 abstr. 34539, No. 3, Sep 2022. Available from: URL: http://doi.org/10.1016/j.jaad.2022.06.906 [abstract]
Rights and permissions
About this article
Cite this article
Alemtuzumab/mogamulizumab/pembrolizumab. Reactions Weekly 1928, 22 (2022). https://doi.org/10.1007/s40278-022-25287-8
Published:
Issue Date:
DOI: https://doi.org/10.1007/s40278-022-25287-8